These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 25200801)

  • 1. Fostering EMA's transparency policy.
    Banzi R; Bertele' V; Demotes-Mainard J; Garattini S; Gluud C; Kubiak C; Ohmann C
    Eur J Intern Med; 2014 Oct; 25(8):681-4. PubMed ID: 25200801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transparency interrupted: the curtailment of the European Medicines Agency's Policy on access to documents.
    Doshi P
    JAMA Intern Med; 2013 Nov; 173(21):2009-11. PubMed ID: 23959623
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trial transparency and orphan drug development: recent trends in data sharing by the pharmaceutical industry.
    So D; Joly Y; Knoppers BM
    Public Health Genomics; 2013; 16(6):322-35. PubMed ID: 24503593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstacles to transparency over pharmacovigilance data within the EMA.
    Prescrire Int; 2015 Nov; 24(165):278-9. PubMed ID: 26688911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMA's transparency seems to be opaque.
    Banzi R; Bertele' V; Garattini S
    Lancet; 2014 Nov; 384(9957):1847. PubMed ID: 25457915
    [No Abstract]   [Full Text] [Related]  

  • 6. European Federation of Statisticians in the Pharmaceutical Industry's position on access to clinical trial data.
    Fletcher C; Driessen S; Burger HU; Gerlinger C; Biesheuvel E;
    Pharm Stat; 2013; 12(6):333-6. PubMed ID: 24136872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to regulatory data from the European Medicines Agency: the times they are a-changing.
    Wieseler B; McGauran N; Kerekes MF; Kaiser T
    Syst Rev; 2012 Oct; 1():50. PubMed ID: 23110993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability.
    Hopkins AM; Rowland A; Sorich MJ
    BMC Med; 2018 Sep; 16(1):165. PubMed ID: 30261889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
    Rose K
    Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The European Medicines Agency's plans for sharing data from clinical trials.
    Groves T; Godlee F
    BMJ; 2013 May; 346():f2961. PubMed ID: 23657192
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trial transparency: many gains but access to evidence for new medicines remains imperfect.
    Mintzes B; Lexchin J; Quintano AS
    Br Med Bull; 2015; 116():43-53. PubMed ID: 26493102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transparency Policies of the European Medicines Agency: Has the Paradigm Shifted?
    Kim D
    Med Law Rev; 2017 Aug; 25(3):456-483. PubMed ID: 28334772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pioneers of transparency.
    Adams B
    BMJ; 2015 Jan; 350():g7717. PubMed ID: 25555823
    [No Abstract]   [Full Text] [Related]  

  • 14. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transparency and the European Medicines Agency--sharing of clinical trial data.
    Bonini S; Eichler HG; Wathion N; Rasi G
    N Engl J Med; 2014 Dec; 371(26):2452-5. PubMed ID: 25539105
    [No Abstract]   [Full Text] [Related]  

  • 16. EMA policy on transparency is "strikingly" similar to deal struck with drug company, say experts.
    Doshi P
    BMJ; 2014 Jun; 348():g3852. PubMed ID: 24924119
    [No Abstract]   [Full Text] [Related]  

  • 17. Bumps and bridges on the road to responsible sharing of clinical trial data.
    Berlin JA; Morris S; Rockhold F; Askie L; Ghersi D; Waldstreicher J
    Clin Trials; 2014 Feb; 11(1):7-12. PubMed ID: 24408901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMA consults public on plan to increase transparency of drug trial data.
    Cohen D
    BMJ; 2013 Jun; 346():f4124. PubMed ID: 23804186
    [No Abstract]   [Full Text] [Related]  

  • 19. The first 2 years of the European Medicines Agency's policy on access to documents: secret no longer.
    Doshi P; Jefferson T
    JAMA Intern Med; 2013 Mar; 173(5):380-2. PubMed ID: 23599918
    [No Abstract]   [Full Text] [Related]  

  • 20. Sharing clinical trial data on patient level: opportunities and challenges.
    Koenig F; Slattery J; Groves T; Lang T; Benjamini Y; Day S; Bauer P; Posch M
    Biom J; 2015 Jan; 57(1):8-26. PubMed ID: 24942505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.